Recent Finacing
Recent Raise
Promethera develops allogeneic liver progenitor cell therapies (HepaStem, H2Stem) and complementary antibody programs for ACLF, NASH and genetic liver disorders, with cGMP manufacturing sites in Belgium and Durham.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Promethera Biosciences.
